The "Fast Money" traders share their final trades of the day.» Read More
Sept 18- Rite Aid Corp cut its full-year profit forecast for the second time in about three months due to lower margins in its pharmacy business, sending its shares down more than 16 percent.
NEW YORK, Sept 3- Some of the best-known technology investors are looking beyond their tried-and-true Internet plays to bet on healthcare data as the next growth market.
Aug 8- McKesson Corp agreed to pay $18 million to settle U.S. charges that it violated its contract with the U.S. Centers for Disease Control and Prevention by falsely assuring that it had been shipping vaccines at the correct temperature.
Aug 8- McKesson Corp agreed to pay $18 million to settle U.S. charges that it violated its contract with the Centers for Disease Control and Prevention by falsely assuring that it had been shipping vaccines at the correct temperature.
R&D tax credits were implemented in 1981 to reverse a dramatic decline in R&D and boost the economy. They don't work. It's time to end them.
The CNBC RQ 50 identifies companies that don't just spend big on R&D, but spend right, creating return on innovation for shareholders.
Using the CNBC RQ 50 measure for R&D productivity, we've identified an elite group of companies that merit election to an R&D hall of fame.
Cramer likes to review the S&P 500’s Daily Action Charts in an effort to find stocks that could work higher.
Some of Thursday's midday movers:
A crush of big cap earnings and arguably the most important economic reports until September make next week the busiest of the summer for markets.
The "Fast Money" traders share their final trades of the day.
Some of 2014's biggest winners are slated to share their next big ideas at this year's Delivering Alpha Conference.
The largest U.S. pharmacy benefit manager, Express Scripts, is cutting back on compounded medications, saying most are ineffective or overpriced.
June 19- Drugstore operator Rite Aid Corp said higher drug costs and a fall in reimbursement rates would continue into the second quarter, sending it shares down 4.4 percent. Rite Aid's shares have been on a tear for most of the past year, until the company warned on first-quarter profit and cut its full-year earnings forecast earlier this month.
McKesson could be in trouble for allegedly favoring one big hedge fund over another.
FRANKFURT, May 21- Hedge fund Magnetar Capital is suing U.S. drugs wholesaler McKesson, saying its acquisition of German peer Celesio short-changed minority shareholders and bondholders by around 370 million euros.
Some of the names on the move ahead of the open.
Check out which companies are making headlines after the bell Monday: Cubic, DirecTV, Rackspace & more
**U.S. drugmaker Pfizer said on April 28 that it had offered to buy Britain's AstraZeneca Plc in January for about $98.9 billion, or nearly 47 pounds per share.
April 10- Rite Aid Corp, the third-largest U.S. drugstore operator, forecast fiscal 2015 sales above analysts' estimates as it benefits from the launch of new generic drugs and enrolls more customers in its loyalty programs.